SGMO today

$0.07-$0.10 (-57.54%)close Jun 23, 2026

Trend

—

Key levels

Resistance$4.61

Resistance$4.26

SANGAMO THERAPEUTICS, INC (SGMO)

$0.07-0.10 (-57.54%)

REDUCEGrade: DRisk: HIGH

1D 5D1M1Y 5Y MaxSign up for all timeframes

High0.12

Low0.06

Open0.08

Volume55.39M

Avg Vol5.06M

VWAP0.09

30d High0.22

30d Low0.07

30d Chg-38.84%

See full chart with real-time data

What Is the Price Target for SGMO?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.07Upside: +0.0%Confidence: 20%Method: No Coverage

Is SGMO a Buy or Sell Right Now?

Investability Score

REDUCE12-18 months

Thesis

•Revenue growing -31.6% YoY with DECLINING trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SGMO.

Start Free Trial →

Is SGMO Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

PEG

Fair Value

$0.16

Moat Score

NONE

2/9

Piotroski Score

-44.0

Altman Z-Score

What Is Smart Money Doing with SGMO?

Insider Signal

NEUTRAL

0 buys / 2 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

UNCHANGED

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Recent Insider Activity

Name	Title	Type	Shares	Value	Date
Jain Nikunj	officer	Sale	1,919	$334.48	May 25, 2026
Davis Gregory D	officer	Sale	1,630	$284.11	May 25, 2026
Dubois-Stringfellow Nathalie	officer	Sale	4,036	$703.47	May 25, 2026
Willoughby Scott B.	officer	Sale	4,036	$703.47	May 25, 2026
Macrae Sandy	director officer	Sale	12,613	$2K	May 25, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

SGMO Growth Story

Revenue YoY

-31.6%

3yr Revenue CAGR

-29.2%

EPS Growth YoY

10.2%

FCF Growth YoY

-44.4%

Revenue Trend

DECLINING

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for SANGAMO THERAPEUTICS, INC (SGMO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

SGMO — frequently asked questions

What is SGMO stock price today?

SANGAMO THERAPEUTICS, INC (SGMO) is at $0.07, down 57.54% (-$0.10) at the Jun 23, 2026 close.

Did SGMO beat earnings?

SGMO last reported on May 14, 2026: EPS -$0.08 vs $0.01 expected — a miss of 900.0%.

Does SGMO pay a dividend?

SGMO does not currently pay a dividend.

What are SGMO support and resistance levels?

Resistance: $4.26, $4.61, $4.76.

What are insiders doing with SGMO?

Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.